Reverse transfections of RNA oligoribonucleotides were performed with Lipofectamine-RNAiMAX (Invitrogen). A total of 50 nM of RNA duplex or 200 check details nM of miRNA inhibitor

were used for each transfection. Cotransfections of RNA duplex with plasmid DNA were performed with Lipofectamine 2000 (Invitrogen). HEK293T cells were transfected with plasmids by calcium phosphate precipitation. Packaging of the retroviral expression vectors and infections of the target cells were performed as described in the Supporting Materials and Methods. Thirty-six hours after the reverse transfections with RNA oligonucleotides, the tumor cells were washed with 1× phosphate-buffered saline (PBS) and were cultured in SFM for 12 hours; tumor cell–conditioned medium (TCM) was collected subsequently as described in Supporting Materials and Methods.

For all experiments, TCM loading was adjusted according to the number of live cells in each sample. Assays to determine the effects of tumor cells or TCM on the migration or capillary tube formation of HUVECs were performed as described in Supporting Materials and Methods. The migration and invasion of tumor cells were analyzed in 24-well Boyden chambers with 8-μm pore size polycarbonate membranes (Corning, NY). For invasion assays, the membranes were coated with Matrigel (3432-005-01, R&D Systems, MN) to form matrix barriers. All experimental procedures involving animals were performed in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes Venetoclax order of Health publication nos. 80-23, revised 1996) and according to the institutional ethical guidelines for animal experiments. For xenograft implantation experiments, 2 × 106 QGY-miR-195-LUC cells were resuspended in 25 μL of PBS/Matrigel (1:1) and were inoculated under the capsule of the left hepatic lobe of male BALB/c nude mice. miR-195 expression was silenced by administering drinking water

that was supplemented with 10% sucrose and 2 mg/mL of doxycycline MycoClean Mycoplasma Removal Kit (Clontech). Bioluminescence imaging and tumor dissection were performed as described in Supporting Materials and Methods. QGY-7703 cells in a 48-well plate were cotransfected with 50 nM of miR-195 or NC duplex, 10 ng of pRL-TK (Promega, Madison, WI), and 50 ng of firefly luciferase reporter plasmid that contained either the wild-type or mutant 3′UTR of the target gene. Forty-eight hours after the transfections, the cell lysates were applied to luciferase assay as described.[3] The levels of VEGF in the TCM were detected using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems) as instructed by the manufacturer. Lysates from QGY-7703 cells were incubated with glutathione-Sepharose bead–immobilized glutathione S-transferase (GST) or GST-PAK. Next, the bead-bound proteins were solubilized in sodium dodecyl sulfate (SDS) buffer and analyzed by immunoblotting.